US FDA approves Bionomics’ cancer drug
The drug targets hard-to-treat colorectal and pancreatic cancers, but may also prove suitable to treat breast, lung and other…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
cancer
TC Biopharm to start phase II/III studies of ImmuniCell in October
Currently focused on skin, renal and lung cancer, the platform has potential to treat all types of cancer tumours as well as viral…
Myriad Genetics partners with Positive Bioscience
To offer first of its kind molecular genetic testing in India
US-based Myriad Genetics announced a strategic partnership with…
Drug to block immune system could stop cancer rebound
Scientists found that cancer-killing action of chemotherapy can trigger a swarm of wound-healing, white blood cells to cluster…
Pancreatic cancer treatment pipeline dominated by early-stage development Research
The high level of first-in-class development in pancreatic cancer therapeutics is a promising sign of the industry seeking…
Molecular tinkering doubles cancer drug’s efficacy
By surrounding molecules of paclitaxel with self-assembling spheres composed of amino acids, the Duke team doubled tumour exposure…
BI’s afatinib LUX-Lung 8 trial data released at ASCO 2015
Patients from 23 countries, including India, participated in the trial, which is reportedly the first prospective trial to…
Boehringer Ingelheim announces OS results from LUX-Lung 8 trial at ASCO 2015
The results of LUX-Lung 8 are very encouraging because they illustrate the clinical relevance of targeting ErbB receptors in this…
Cancer Genetics in agreement with ReproCELL
CGI expects to process several thousand samples over the next two years at the company’s genomic lab in Hyderabad to aid ReproCELL…
Merck receives FDA Fast Track Designation for Evofosfamide
It will help in treating patients living with advanced pancreatic cancer